Key result
Quinidine sulfate and bishydroxycoumarin reduced mortality and morbidity compared to bishydroxycoumarin alone or conventional measures in decompensated patients with atrial fibrillation.
Why the study?
Does the addition of bishydroxycoumarin with or without quinidine reduce morbidity and mortality in hospitalized, decompensated cardiac patients with atrial fibrillation?
Does the addition of bishydroxycoumarin with or without quinidine reduce morbidity and mortality in hospitalized, decompensated cardiac patients with atrial fibrillation?
In hospitalized patients with decompensated heart failure and atrial fibrillation, anticoagulation with bishydroxycoumarin reduces mortality and thromboembolic events, with further morbidity and mortality benefits when combined with quinidine.
Answers are grounded in this paper and cite their sources.
May support quinidine plus anticoagulation in decompensated AF; leaves open confirmation by randomized trials.
Theoretically, chronic atrial fibrillation adversely affects individuals with organic heart disease from the standpoint of increased incidence of thromboembolic phenomena and resistant decompensation. This study was designed to demonstrate the effects on rates of morbidity and mortality of anticoagulation and reversion to normal sinus rhythm. Three hundred hospitalized, decompensated cardiac patients with atrial fibrillation of more than 18 days' duration were treated by conventional measures of bed rest, salt restriction, and administration of digitalis and diuretics. One hundred served as a control group; the second 100 received quinidine sulfate and bishydroxycoumarin (Dicumarol); and the third 100 were given bishydroxycoumarin but no quinidine. Rates of mortality and morbidity were highest in the control group and lowest in the second group. Mortality and the nonfatal thromboembolic rates were diminished in the group which received anticoagulants alone, but the incidence of persistent decompensation was unchanged.
No takes yet. Share an insight, caveat, or question.
Irving Freeman (1963) studied Atrial fibrillation with decompensated heart disease (n=300). Quinidine sulfate and bishydroxycoumarin, or bishydroxycoumarin alone vs. Conventional measures (bed rest, salt restriction, digitalis, and diuretics) was evaluated on Mortality and morbidity. Quinidine sulfate and bishydroxycoumarin reduced mortality and morbidity compared to bishydroxycoumarin alone or conventional measures in decompensated patients with atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: